MNKD Q3 2020 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+5.2% YoY

Gross Profit

$10M66.3% margin

Operating Income

-$9M-59.5% margin

Net Income

-$11M-73.3% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$96M

Total Liabilities

$282M

Stockholders' Equity

-$186M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$15M	+5.2%
Gross Profit	$10M	$6M	+79.9%
Operating Income	-$9M	-$9M	-4.0%
Net Income	-$11M	-$10M	-8.5%

Revenue Segments

Product

$7M82%

License And Service

$2M18%